<DOC>
	<DOC>NCT00676403</DOC>
	<brief_summary>To test the effectiveness and tolerability of Lyrica at various dose levels in RLS patients</brief_summary>
	<brief_title>Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Moderate to severe idiopathic RLS symptoms occur predominantly in the evening symptoms interfere with sleep onset or maintenance Any secondary RLS require treatment for daytime RLS symptoms symptomatic neuropathies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>pregabalin, RLS, efficacy, safety</keyword>
</DOC>